Literature DB >> 9543164

Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor 1 are elevated in thyroid hyperplasia.

S D Thompson1, J A Franklyn, J C Watkinson, J M Verhaeg, M C Sheppard, M C Eggo.   

Abstract

We have previously reported increased expression of fibroblast growth factor (FGF-1 and FGF-2) in benign and malignant human thyroid neoplasia. To determine the role of these factors in thyroid hyperplasia we have examined their expression in multinodular goiter and compared findings with those in normal thyroid tissue. Because the effects of FGF-1 and FGF-2 are predominantly mediated through the FGF receptor-1 (FGFR-1), its expression has also been examined. Immunocytochemistry was performed on sections from multinodular goiters (n = 18) and normal thyroid (n = 7). Cytoplasmic staining for FGF-1, FGF-2, and FGFR-1 was scored on a scale of 0 (no staining) to 3 (heavy staining) and expressed as a percentage of total cells stained. Confocal microscopy of immunofluorescent staining for FGF-1, FGF-2, and FGFR-1 in sections of multinodular goiter (n = 3) and normal thyroid (n = 3) provided quantitation of immunostaining. FGF-1 expression was significantly increased in multinodular goiter when compared with normal. A mean of 74% of follicular cells in multinodular goiter compared with 9% of follicular cells in normal thyroid expressed FGF-1 (P < 0.0001). When expression of FGF-2 was examined, 77% of the follicular cells in multinodular goiter compared with 5% in normal thyroids were immunopositive (P < 0.0001). Confocal microscopy revealed that the intensity was 160 times greater in follicular cells in sections of multinodular goiters when compared with normal. When expression of FGFR-1 was analyzed, 89% of the follicular cells in multinodular goiter stained positively, compared with 15% of follicular cells in sections of normal thyroid. Confocal microscopy revealed a 6-fold increase in intensity of FGFR-1 expression in follicular cells of multinodular goiter (P < 0.05). In addition, there was significant nuclear expression of FGFR-1 in multinodular goiter contrasting with negligible expression in normal thyroid. These data show that enhanced expression of FGF-1, FGF-2, and FGFR-1 accompany thyroid hyperplasia and are not exclusively associated with the neoplastic state. These factors may be involved in the pathogenesis of uncontrolled thyroid growth observed in these conditions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9543164     DOI: 10.1210/jcem.83.4.4723

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Cell aggregation-induced FGF8 elevation is essential for P19 cell neural differentiation.

Authors:  Chen Wang; Caihong Xia; Wei Bian; Li Liu; Wei Lin; Ye-Guang Chen; Siew-Lan Ang; Naihe Jing
Journal:  Mol Biol Cell       Date:  2006-04-26       Impact factor: 4.138

2.  Fifteen years' experience in thyroid surgery.

Authors:  John C Watkinson
Journal:  Ann R Coll Surg Engl       Date:  2010-10       Impact factor: 1.891

3.  Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse.

Authors:  Klementina Fon Tacer; Angie L Bookout; Xunshan Ding; Hiroshi Kurosu; George B John; Lei Wang; Regina Goetz; Moosa Mohammadi; Makoto Kuro-o; David J Mangelsdorf; Steven A Kliewer
Journal:  Mol Endocrinol       Date:  2010-07-28

4.  Iodine deficiency induces a thyroid stimulating hormone-independent early phase of microvascular reshaping in the thyroid.

Authors:  Anne-Catherine Gérard; Sylvie Poncin; Bertrand Caetano; Pierre Sonveaux; Jean-Nicolas Audinot; Olivier Feron; Ides M Colin; Fabrice Soncin
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

5.  Levothyroxine therapy in preventing nodular recurrence after hemithyroidectomy: a retrospective study.

Authors:  M Alba; D Fintini; R M Lovicu; R M Paragliola; G Papi; C A Rota; A Pontecorvi; S M Corsello
Journal:  J Endocrinol Invest       Date:  2009-04       Impact factor: 4.256

Review 6.  Toxic multinodular goitre. Personal case histories and literature review.

Authors:  Gia Sturniolo; E Gagliano; A Tonante; F Taranto; F Vermiglio; Gio Sturniolo
Journal:  G Chir       Date:  2013 Sep-Oct

7.  Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals.

Authors:  R M Ruggeri; S Sciacchitano; A Vitale; P Cardelli; M Galletti; E Vitarelli; G Barresi; S Benvenga; F Trimarchi; M Trovato
Journal:  J Endocrinol Invest       Date:  2009-03-25       Impact factor: 4.256

8.  High prevalence of thyroid ultrasonographic abnormalities in primary aldosteronism.

Authors:  Decio Armanini; Davide Nacamulli; Carla Scaroni; Franco Lumachi; Riccardo Selice; Cristina Fiore; Gennaro Favia; Franco Mantero
Journal:  Endocrine       Date:  2003-11       Impact factor: 3.925

9.  Fibroblast growth factor receptor-2 expression in thyroid tumor progression: potential diagnostic application.

Authors:  Adriano Redler; Giorgio Di Rocco; Domenico Giannotti; Francesca Frezzotti; Maria Giulia Bernieri; Simona Ceccarelli; Sirio D'Amici; Enrica Vescarelli; Anna Paola Mitterhofer; Antonio Angeloni; Cinzia Marchese
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

10.  Histopathological Changes of the Thyroid and Parathyroid Glands in HIV-Infected Patients.

Authors:  Rabia Cherqaoui; K M Mohamed Shakir; Babak Shokrani; Sujay Madduri; Faria Farhat; Vinod Mody
Journal:  J Thyroid Res       Date:  2014-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.